Tucker Asset Management’s Unity Biotechnology UBX Stock Holding History

Tucker Asset Management’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4	Closed	-$114	–	920
2022 Q3	$114	Sell	4 -36	-90%	-$227	﹤0.01%	823
2022 Q2	$225	Buy	+40	New	+$334	﹤0.01%	618

Other funds holding UBX

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tucker Asset Management's UBX Position: Q4 2022 in Review

Tucker Asset Management sold out of Unity Biotechnology (UBX) in Q4 2022, closing a stake of 4 shares — an estimated $114 sold.

Tucker Asset Management first reported a position in UBX in Q2 2022 and held it in 2 quarters. The position peaked at $225 in Q2 2022. 54 funds tracked by Wall St. Rank hold UBX as of Q4 2022.

Tucker Asset Management reported no remaining Unity Biotechnology position as of Q4 2022 after selling out during the quarter.
Tucker Asset Management sold 4 Unity Biotechnology shares in Q4 2022, an estimated $114.
Tucker Asset Management first reported a position in Unity Biotechnology in Q2 2022 and held it in 2 quarters.
Tucker Asset Management's Unity Biotechnology position peaked at $225 in Q2 2022.
54 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2022.

Based on Tucker Asset Management's 13F filing for Q4 2022, filed 11 May 2023.